Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
AUTOR(ES)
Ternant, David
FONTE
Blackwell Science Inc
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2780281Documentos Relacionados
- DNA flow cytometry of follicular non-Hodgkin's lymphoma.
- Aggressive Non-Hodgkin's Lymphoma: therapeutic considerations of pre rituximab era
- Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma
- Non-Hodgkin's lymphoma: initial manifestation.
- Non-Hodgkin's lymphoma in rheumatoid arthritis.